trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Neoplasms D009369 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Radiation Injuries D011832 14 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Brain Neoplasms D001932 15 associated lipids
Carcinoma D002277 18 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Leishmaniasis D007896 19 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Xiao H et al. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. 1999 J. Cell. Biochem. pmid:10321829
Mielnicki LM et al. Epigenetic regulation of gelsolin expression in human breast cancer cells. 1999 Exp. Cell Res. pmid:10328963
Finnin MS et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. 1999 Nature pmid:10490031
Huang Y et al. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. 1999 Nat. Neurosci. pmid:10491605
List HJ et al. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter. 1999 Exp. Cell Res. pmid:10527637
Fukuda K Apoptosis-associated cleavage of beta-catenin in human colon cancer and rat hepatoma cells. 1999 Mar-Apr Int. J. Biochem. Cell Biol. pmid:10224675
Liou JS et al. Oncogenic ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species. 2000 J. Biol. Chem. pmid:10967125
Mariadason JM et al. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. 2000 Cancer Res. pmid:10969808
Fu M et al. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. 2000 J. Biol. Chem. pmid:10779504
Gays F et al. The mouse tumor cell lines EL4 and RMA display mosaic expression of NK-related and certain other surface molecules and appear to have a common origin. 2000 J. Immunol. pmid:10799866
McInerney JM et al. Long-term silencing of retroviral vectors is resistant to reversal by trichostatin A and 5-azacytidine. 2000 Gene Ther. pmid:10800088
McBlane F and Boyes J Stimulation of V(D)J recombination by histone acetylation. 2000 Curr. Biol. pmid:10801420
Hobbs CA and Gilmour SK High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation. 2000 J. Cell. Biochem. pmid:10760944
Yoshida M and Horinouchi S [Histone deacetylase inhibitors--new anticancer agents?]. 2000 Tanpakushitsu Kakusan Koso pmid:10771678
Yu F et al. Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. 2000 Nucleic Acids Res. pmid:10773092
Huang X et al. Nitric oxide (NO), methylation and TIMP-1 expression in BL6 melanoma cells transfected with MHC class I genes. 2000 Clin. Exp. Metastasis pmid:11448064
Kitamura K et al. Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid. 2000 Br. J. Haematol. pmid:10792271
Saleh M et al. Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases. 2000 Mol. Cell. Biol. pmid:11046157
Diamond SE and Gutierrez-Hartmann A The Pit-1beta domain dictates active repression and alteration of histone acetylation of the proximal prolactin promoter. 2000 J. Biol. Chem. pmid:10921928
Chang LK and Liu ST Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. 2000 Nucleic Acids Res. pmid:11024171
Andoh A et al. Modulation of complement component (C3 and factor B) biosynthesis by a histone deacetylase inhibitor in human intestinal epithelial cells. 2000 Int. J. Mol. Med. pmid:10851266
Suzuki T et al. Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines. 2000 Int. J. Cancer pmid:11093826
Sutcliffe JE et al. Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription. 2000 Mol. Cell. Biol. pmid:11094071
Magner WJ et al. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. 2000 J. Immunol. pmid:11120829
Damjanovski S et al. Multiple stage-dependent roles for histone deacetylases during amphibian embryogenesis: implications for the involvement of extracellular matrix remodeling. 2000 Int. J. Dev. Biol. pmid:11128570
Liang L et al. Dynamic readjustment of parental methylation patterns of the 5'-flank of the mouse H19 gene during in vitro organogenesis. 2000 Int. J. Dev. Biol. pmid:11128572
Gaetano C et al. Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo. 2000 Gene Ther. pmid:11083470
Maecker HL et al. p53 promotes selection for Fas-mediated apoptotic resistance. 2000 Cancer Res. pmid:10969818
Siavoshian S et al. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. 2000 Gut pmid:10716680
Su GH et al. A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. 2000 Cancer Res. pmid:10866300
Lin F et al. Unique anti-activator protein-1 activity of retinoic acid receptor beta. 2000 Cancer Res. pmid:10866321
Hemavathy K et al. Human Slug is a repressor that localizes to sites of active transcription. 2000 Mol. Cell. Biol. pmid:10866665
Jin S et al. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10841572
Claassen GF and Hann SR A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10920185
Mao C and Shapiro DJ A histone deacetylase inhibitor potentiates estrogen receptor activation of a stably integrated vitellogenin promoter in HepG2 cells. 2000 Endocrinology pmid:10875235
Clayton AL et al. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. 2000 EMBO J. pmid:10899125
Kang J et al. Heat shock protein 90 mediates protein-protein interactions between human aminoacyl-tRNA synthetases. 2000 J. Biol. Chem. pmid:10913161
Yu J et al. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. 2000 Mol. Cell. Biol. pmid:10713181
Adachi N et al. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation. 2000 Gene pmid:10713444
Shin JY et al. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. 2000 Cancer Res. pmid:10667572
Stöckel B et al. Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene. 2000 Eur. J. Biochem. pmid:10691972
Imai S et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. 2000 Nature pmid:10693811
Sirchia SM et al. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells. 2000 Oncogene pmid:10734315
Hu JF et al. Allele-specific histone acetylation accompanies genomic imprinting of the insulin-like growth factor II receptor gene. 2000 Endocrinology pmid:11108251
Hodny Z et al. Sp1 and chromatin environment are important contributors to the formation of repressive chromatin structures on the transfected human adenine nucleotide translocase-2 promoter. 2000 Biochem. J. pmid:10657244
Garrison PM et al. Effects of histone deacetylase inhibitors on the Ah receptor gene promoter. 2000 Arch. Biochem. Biophys. pmid:10666294
Kim YB et al. Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells. 2000 J. Antibiot. pmid:11132966
Nakayama T et al. Epigenetic regulation of androgen receptor gene expression in human prostate cancers. 2000 Lab. Invest. pmid:11140692
Pender SL et al. Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11052988
Tobias CA et al. Improved recombinant retroviral titers utilizing trichostatin A. 2000 BioTechniques pmid:11056820